Decoy Therapeutics raises $3.5M upfront in PIPE, up to $21M with milestone warrants

Decoy Therapeutics Inc.

Gross proceeds of $3.5M from sale of 592,217 shares (or pre-funded warrants) at $5.91/share.
Milestone warrants could add $3.5M (Series A), $7.0M (Series B), and $7.0M (Series C) if triggered.
Proceeds to advance lead asset into clinical trials; closing expected June 29, 2026.
Executives and directors subject to 90-day lock-up; Curvature Securities acting as placement agent.
Registration rights agreement requires filing resale registration statement within 15 calendar days.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.